二 | 另有1例无症状感染者转确诊病例已通报。    Ranveer Singh's Dhurandhar had an explosive opening at the Indian box office. The Aditya Dhar directorial is a spy thriller revolving around a RAW agent and his covert missions in the criminal underworld of Karachi and its link to India. According to industry tracker Sacnilk, the film has earned Rs 27 crore on its release day, December 5.     This surpasses the predictions made by trade experts, who estimated the film's opening day earnings to fall in the range of Rs 15-18 crore. With a stronger start than Saiyaara, which collected Rs ₹21.50 crore on Day 1, Dhurandhar has already outperformed expectations.               It has also come very close to Chhaava's opening day collection of Rs 31 crore, making it a solid comeback for Singh. Dhurandhar has now recorded the third-biggest opening of 2025 after War 2 (Rs 52 crore) and Chhaava. It also stands as Ranveer Singh's biggest opener to date, surpassing his previous record, Simmba, which opened at Rs 20 crore in 2018.     Besides Ranveer, Dhurandhar features an ensemble cast featuring Akshaye Khanna, R Madhavan, Sanjay Dutt, Sara Arjun, Rakesh Bedi and Arjun Rampal among others.                    Filmfare's Review of Dhurandhar     Filmfare rated the film 3.5 out of 5 and said in its review, "At the centre of this world stands Ranveer Singh, playing the hard-edged agent who slips into the shadow world of sleeper operatives as a cross-border conspiracy erupts. It’s a performance of restraint, a departure from his flamboyant screen persona. This Ranveer is raw yet internalised, driven yet fraying. The role demands both physical ferocity and emotional weariness, and he delivers both with remarkable control. His silences speak as loudly as his action beats, grounding the film even when its narrative ambitions begin to overtake its focus."     Meanwhile, Dhurandhar's sequel will be released in March next year.     Also Read: Yami Gautam Praises Aditya Dhar’s Hard Work As Dhurandhar Releases in Theatres。9月13日0时至15时，新增本土新冠肺炎病毒感染者16例，均为隔离观察人员，其中，朝阳区13例、昌平区2例、大兴区1例；均为轻型。

三 | 上述病例已转至定点医院隔离治疗，已开展流行病学调查和密切接触者追踪，对涉及的风险点位进行排查，对各类风险人员实施分类管控。

四 | 现将相关情况通报如下：感染者126、128：均为感染者30的同校学生。9月12日作为密切接触者进行核酸检测，报告结果为阳性，9月13日诊断为确诊病例，临床分型均为轻型。感染者127、129至139：均为感染者87的同校学生。9月12日、13日作为密切接触者进行核酸检测，报告结果为阳性，9月13日诊断为确诊病例，临床分型均为轻型。感染者140：现住大兴区亦庄镇小康家园，9月9日曾前往感染者88、89就诊的医院就诊，9月10日作为风险人员进行居家隔离，9月12日转至集中隔离，自述9月11日出现咽部不适、流涕、发热等症状，9月13日报告核酸检测结果为阳性，当日诊断为确诊病例，临床分型为轻型。

五 | 感染者141：现住朝阳区平房乡泓鑫家园，9月9日曾前往感染者88、89就诊的医院就诊，9月10日作为风险人员进行居家隔离，9月12日转至集中隔离，9月13日报告核酸检测结果为阳性，当日诊断为确诊病例，临床分型为轻型。今日通报的感染者141在9月10日接到流调电话后，取消了原定的亲友聚餐、看电影等活动，居家隔离未外出，该感染者主动配合防疫措施，积极履行个人防疫主体责任，明显减少了疫情传播风险。

六 |

Current article:http://rw9k7.ruandaimingyunsun.sbs/news/20260826_121080.html

Published on:05:43:43